STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021		40,473,270
Beginning balance at Dec. 31, 2021	$ 225,183	$ 4	$ 352,981	$ (127,571)	$ (231)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for cash, net of issuance costs (in shares)		422,160
Issuance of common stock for cash, net of issuance costs	3,792		3,792
Unrealized (loss) gain on marketable securities	(520)				(520)
Stock options exercised for cash (in shares)		124,886
Stock options exercised for cash	115		115
Cashless exercise of stock options (in shares)		4,746
Stock-based compensation	3,061		3,061
Net loss	$ (42,856)			(42,856)
Ending balance (in shares) at Dec. 31, 2022	41,025,062	41,025,062
Ending balance at Dec. 31, 2022	$ 188,775	$ 4	359,949	(170,427)	(751)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for cash, net of issuance costs (in shares)		16,774,193
Issuance of common stock for cash, net of issuance costs	121,904	$ 2	121,902
Unrealized (loss) gain on marketable securities	$ 1,063				1,063
Stock options exercised for cash (in shares)	111,206	111,206
Stock options exercised for cash	$ 325		325
Issuance of warrant with Term Loan	1,132		1,132
Stock-based compensation	6,145		6,145
Net loss	$ (52,371)			(52,371)
Ending balance (in shares) at Dec. 31, 2023	57,910,461	57,910,461
Ending balance at Dec. 31, 2023	$ 266,973	$ 6	$ 489,453	$ (222,798)	$ 312